29524-58-1

Basic information

• Product Name: methyl 4-((3,7-dimethylocta-2,6-dien-1-yl)oxy)benzoate
• Synonyms: methyl 4-((3,7-dimethylocta-2,6-dien-1-yl)oxy)benzoate
• CAS NO: 29524-58-1
• Molecular Weight: 288.387
• Mol File: 29524-58-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: methyl 4-((3,7-dimethylocta-2,6-dien-1-yl)oxy)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-((3,7-dimethylocta-2,6-dien-1-yl)oxy)benzoate(29524-58-1)
• EPA Substance Registry System: methyl 4-((3,7-dimethylocta-2,6-dien-1-yl)oxy)benzoate(29524-58-1)

Safety Data

• Hazardous Substances Data: 29524-58-1(Hazardous Substances Data)

Upstream product

• 6138-90-5 trans-geranyl bromide 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 4490-10-2 geranyl chloride 

Downstream Products

• 27780-71-8 p-[(3,7-dimethyl-2,6-octadienyl)oxy]benzoic acid 

Relevant articles and documents

2-Aryl benzazole derived new class of anti-tubercular compounds: Endowed to eradicate mycobacterium tuberculosis in replicating and non-replicating forms

The high mortality rate and the increasing prevalence of Mtb resistance are the major concerns for the Tuberculosis (TB) treatment in this century. To counteract the prevalence of Mtb resistance, we have synthesized 2-aryl benzazole based dual targeted molecules. Compound 9m and 9n were found to be equally active against replicating and non-replicating form of Mtb (MIC(MABA) 1.98 and 1.66 μg/ml; MIC(LORA) 2.06 and 1.59 μg/ml respectively). They arrested the cell division (replicating Mtb) by inhibiting the GTPase activity of FtsZ with IC50 values 45 and 64 μM respectively. They were also capable of kill Mtb in non-replicating form by inhibiting the biosynthesis of menaquinone which was substantiated by the MenG inhibition (IC50 = 11.62 and 7.49 μM respectively) followed by the Vit-K2 rescue study and ATP production assay.

Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug

A pyrrolidine derivative or a salt thereof expressed by the following formula 1: STR1 wherein R1 is an alkenyl group; R2 is a lower alkoxy group or a halogen atom; R3 is a lower alkyl group; X is a group expressed by --O-- or --S--; Y is carbon or nitrogen atom; m is an integer of 1 to 3; and n is an integer of 0 to 2. The pyrrolidine derivative has an anti-ulcer effect or an antibacterial activity against Helicobacter pyroli, and has also high safety to be available for prevention or cure of ulcers.

Alkylenediamine derivative anti-ulcer drug and antibacterial drug

The invention provides a compound which has anti-ulcer effect and antibacterial activity against Helicobacter pyroli. This compound is an alkylenediamine derivative or salt which has a general formula of (1): STR1 wherein each of R4, R5/s